Mirabella Financial Services LLP Biolife Solutions Inc Transaction History

Mirabella Financial Services LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $387,609 - $571,871	21,936 New	21,936 $477,000
Q3 2022 Oct 26, 2022	SELL	$14.64 - $26.7 $123,166 - $224,627	-8,413 Reduced 19.64%	34,422 $783,000
Q2 2022 Aug 12, 2022	BUY	$10.54 - $24.2 $451,480 - $1.04 Million	42,835 New	42,835 $592,000
Q1 2022 May 17, 2022	SELL	$20.81 - $37.29 $527,117 - $944,555	-25,330 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $672,897 - $1.19 Million	-20,397 Reduced 44.61%	25,330 $944,000
Q3 2021 Nov 15, 2021	BUY	$42.03 - $60.5 $39,424 - $56,749	938 Added 2.09%	45,727 $1.93 Million
Q2 2021 Aug 13, 2021	BUY	$29.51 - $44.62 $853,665 - $1.29 Million	28,928 Added 182.38%	44,789 $1.99 Million
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $522,619 - $701,690	15,861 New	15,861 $571,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.